Claritev Return on Tangible Equity 2019-2025 | CTEV

Current and historical return on tangible equity values for Claritev (CTEV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Claritev Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-1.18B $-4.53B 25.80%
2024-12-31 $-1.65B $-4.55B 35.77%
2024-09-30 $-1.54B $-4.56B 33.07%
2024-06-30 $-1.17B $-4.61B 24.87%
2024-03-31 $-0.63B $-4.69B 13.21%
2023-12-31 $-0.09B $-4.75B 1.90%
2023-09-30 $-0.71B $-4.80B 14.72%
2023-06-30 $-0.67B $-4.87B 13.70%
2023-03-31 $-0.62B $-4.77B 12.54%
2022-12-31 $-0.57B $-4.86B 11.41%
2022-09-30 $0.10B $-4.96B -2.01%
2022-06-30 $0.16B $-5.07B -3.08%
2022-03-31 $0.10B $-5.17B -1.87%
2021-12-31 $0.10B $-5.30B -1.88%
2021-09-30 $-0.10B $-5.38B 1.77%
2021-06-30 $-0.46B $-5.49B 12.12%
2021-03-31 $-0.47B $-5.53B 21.68%
2020-12-31 $-0.52B $-5.28B 99.47%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.699B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.182B 58.76
Doximity (DOCS) United States $11.140B 51.57
Hims & Hers Health (HIMS) United States $10.623B 110.37
Tempus AI (TEM) United States $10.245B 0.00
IRhythm Technologies (IRTC) United States $4.558B 0.00
Inspire Medical Systems (INSP) United States $3.855B 60.24
Hinge Health (HNGE) United States $3.480B 0.00
Privia Health (PRVA) United States $2.672B 182.67
Enovis (ENOV) United States $1.911B 10.66
Phreesia (PHR) United States $1.730B 0.00
10x Genomics (TXG) United States $1.602B 0.00
Schrodinger (SDGR) United States $1.538B 0.00
Azenta (AZTA) United States $1.504B 69.89
Omnicell (OMCL) United States $1.396B 24.63
Evolent Health (EVH) United States $1.377B 117.30
Clover Health Investments (CLOV) United States $1.318B 0.00
Fulgent Genetics (FLGT) United States $0.612B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.520B 0.00
Butterfly Network (BFLY) United States $0.485B 0.00
Talkspace (TALK) United States $0.440B 131.50
Outset Medical (OM) United States $0.365B 0.00
TruBridge (TBRG) United States $0.340B 755.33
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.262B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.168B 0.00
American Well (AMWL) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.131B 0.00
Pulmonx (LUNG) United States $0.110B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
CareCloud (CCLD) United States $0.104B 3.95
Insight Molecular Diagnostics (IMDX) United States $0.087B 0.00
111 (YI) China $0.063B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.049B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.044B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00